AACR-Bayer Innovation and Discovery Grants
April 28, 2020 – Grant recipient must attend the Grants Reception and Dinner to formally accept the grant. Funds for travel support to this Annual Meeting will be provided separate from the grant.
Bayer and the AACR are proud to announce the 2020 AACR-Bayer Innovation and Discovery Grants.
This grants partnership promotes the key tenets of the Bayer Grants4Targets™ Initiative, providing new treatment options for cancers with high unmet medical need, encouraging innovation and translation of ideas from basic research into novel drugs, and fostering collaborations between excellent academic groups and the pharmaceutical industry.
Each grant provides $50,000 to meritorious projects that examine important and druggable*, novel targets and biomarkers.
All applicants with questions about eligibility should contact the AACR’s Scientific Review and Grants Administration Department (the AACR’s SRGA) at [email protected] before submitting an application.
Program Guidelines and Application Instructions are available for download.
These grants will support basic, translational, and/or clinical research projects that examine important and druggable* novel targets and/or biomarkers. The proposed research must be focused in area(s) of oncogenetic signaling, immuno-oncology, and/or antibody drugs/thorium conjugates.
*For the purposes of this grant program, a "druggable" target is defined as a nucleic acid or a protein (e.g., an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular weight chemical compound or a biological, such as an antibody or a recombinant protein. The target should have been shown to be effective/mechanistically involved in cancer by relevant in vitro or in vivo models. A cancer-related biomarker might be a protein, a nucleic acid, or a metabolite that can be measured in biological fluids, tissue, or isolated cells for the diagnosis, monitoring, prognosis, or stratification of patients.
Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
Applications will be accepted from independent investigators who are affiliated with an academic, medical, or research institution within North America.
Investigators may submit only one application for a AACR-Bayer Innovation and Discovery Grants but may concurrently apply for other AACR grants.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. Employees or subcontractors of a U.S. government entity or for‐profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.
Members of the Scientific Review Committee are not eligible to apply for an AACR-Bayer Innovation and Discovery Grant.
There are no citizenship requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.
AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active Membership by the grant application deadline. Nonmembers can apply for membership using the Official Application for Membership Form submitted to AACR with the required documents. Please review the Membership Categories for the category that best fits your qualifications. Members can renew their membership through myAACR to bring their membership current. You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please contact [email protected]. Lapsed members must be members in good standing by the application deadline and should contact the Membership Department at [email protected] for assistance.